Eine erfolgreiche Tabakentwöhnung verbessert bei Patienten mit Bronchialkarzinom die Prognose quoad vitam. Dennoch wird Rauchern mit einem nicht-kleinzelligen Bronchialkarzinom und geplanter kurativer Resektion häufig davon abgeraten, das Rauchen in der unmittelbaren präoperativen Phase einzustellen. Diese Empfehlung stützt sich auf eine prospektive Kohortenstudie aus dem Jahre 1998, in der eine Reduktion des Tabakkonsums in den letzten acht Wochen vor einem nicht-thorakalen Eingriff mit einer Erhöhung des Risikos für perioperative pulmonale Komplikationen einherging. Zwar wurden in den vergangenen 12 Jahren zahlreiche weitere Beobachtungsstudien zu den Auswirkungen einer präoperativen Entwöhnung auf das perioperative Risiko bei thorakalen und nicht-thorakalen Operationen publiziert – nur sechs dieser Arbeiten bezogen sich jedoch auf Patienten mit Lungentumoren. Aufgrund methodischer Schwächen und der großen Heterogenität der untersuchten Patientengruppen lässt sich aus den vorliegenden Daten keine Empfehlung für oder gegen einen Rauchstop in der unmittelbaren präoperativen Phase ableiten. Unter Berücksichtigung der für perioperative Komplikationen relevanten pathophysiologischen Prozesse und des zeitlichen Verlaufs ihrer Erholung nach einer Tabakentwöhnung erscheint eine mindestens zwei- bis sechswöchige präoperative Rauchkarenz sinnvoll; im Kontext der meist dringlichen Indikation zur kurativen Resektion erscheint dies zuweilen unrealistisch. Da aber auch kürzere präoperative Abstinenzphasen die Prognose nicht nachweislich verschlechtern, sollten Patienten mit Bronchialkarzinom eine Empfehlung zur präoperativen Tabakentwöhnung erhalten.
Abstract
Successful smoking cessation is associated with a survival benefit for patients with lung cancer. However, smokers newly diagnosed with non-small cell lung cancer and scheduled for curative resection are frequently discouraged from stopping smoking in the immediate preoperative period. This recommendation is based on the results of one single prospective cohort study published in 1998 which reported an increased risk of perioperative pulmonary complications in patients undergoing non-thoracic surgery who had reduced their tobacco consumption within the two months leading up to the operation. During the past 12 years, numerous observational studies have investigated the impact of preoperative smoking cessation on perioperative risk for thoracic and non-thoracic surgery. However, no more than six studies included patients with pulmonary neoplasms. Owing to methodological limitations and considerable heterogeneity of the included patient groups, the existing data are insufficient to support or refuse any recommendation regarding cessation advice for patients during the immediate preoperative phase. In view of the post-cessation recovery time-course of pathophysiological alterations relevant to the occurrence of perioperative complications, a smoke-free preoperative interval of 2 – 6 weeks appears most favourable. However, this is difficult to achieve as a curative resection should not be postponed. Since there is no scientific evidence demonstrating a negative impact of preoperative smoking cessation on prognosis, patients newly diagnosed with lung cancer should be encouraged to make an attempt to quit while waiting for thoracic surgery.
1 Diese Übersichtsarbeit wurde in ihren Grundzügen auf dem 51. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V. im Rahmen eines Symposiums vorgestellt.
Literatur
1
Goeckenjan G, Sitter H, Thomas M. et al .
Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms. Interdisziplinäre S3-Leitlinie der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin und der Deutschen Krebsgesellschaft.
Pneumologie.
2010;
64 Suppl 2
e1-e164
2
Simonato L, Agudo A, Ahrens W. et al .
Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of inter-country heterogeneity.
Int J Cancer.
2001;
91
876-887
3 Tobacco or health in the European Union – past, present and future. Prepared by the ASPECT Consortium. 2004, Luxemburg: Office for Official Publication of the European Communities. 25-68
4
Bryant A, Cerfolio R J.
Differences in epidemiology, histology, and survival between cigarette smokers and never-smokers who develop non-small cell lung cancer.
Chest.
2007;
132
185-192
5
Richardson G E, Tucker M A, Venzon D J. et al .
Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers.
Ann Intern Med.
1993;
119
383-390
6
Parsons A, Daley A, Begh R. et al .
Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: systematic review of observational studies with meta-analysis.
Bmj.
2010;
340
b5569
7
Fox J L, Rosenzweig K E, Ostroff J S.
The effect of smoking status on survival following radiation therapy for non-small cell lung cancer.
Lung Cancer.
2004;
44
287-293
8
Videtic G M, Stitt L W, Dar A R. et al .
Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival.
J Clin Oncol.
2003;
21
1544-1549
10
Fielding L P, Phillips R K, Hittinger R.
Factors influencing mortality after curative resection for large bowel cancer in elderly patients.
Lancet.
1989;
1
595-597
11
Vaporciyan A A, Merriman K W, Ece F. et al .
Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation.
Ann Thorac Surg.
2002;
73
420-425; discussion 425 – 426
13
Nakagawa M, Tanaka H, Tsukuma H. et al .
Relationship between the duration of the preoperative smoke-free period and the incidence of postoperative pulmonary complications after pulmonary surgery.
Chest.
2001;
120
705-710
14
Mitchell C K, Smoger S H, Pfeifer M P. et al .
Multivariate analysis of factors associated with postoperative pulmonary complications following general elective surgery.
Arch Surg.
1998;
133
194-198
15
Schwilk B, Bothner U, Schraag S. et al .
Perioperative respiratory events in smokers and nonsmokers undergoing general anaesthesia.
Acta Anaesthesiol Scand.
1997;
41
348-355
17
Moller A M, Pedersen T, Villebro N. et al .
Effect of smoking on early complications after elective orthopaedic surgery.
J Bone Joint Surg Br.
2003;
85
178-181
18
Myles P S, Iacono G A, Hunt J O. et al .
Risk of respiratory complications and wound infection in patients undergoing ambulatory surgery: smokers versus nonsmokers.
Anesthesiology.
2002;
97
842-847
19
Harpole Jr. D H, DeCamp Jr. M M, Daley J. et al .
Prognostic models of thirty-day mortality and morbidity after major pulmonary resection.
J Thorac Cardiovasc Surg.
1999;
117
969-979
20
Moller A M, Villebro N, Pedersen T. et al .
Effect of preoperative smoking intervention on postoperative complications: a randomised clinical trial.
Lancet.
2002;
359
114-117
21
Lindstrom D, Sadr Azodi O, Wladis A. et al .
Effects of a perioperative smoking cessation intervention on postoperative complications: a randomized trial.
Ann Surg.
2008;
248
739-745
24
Sardari Nia P, Weyler J, Colpaert C. et al .
Prognostic value of smoking status in operated non-small cell lung cancer.
Lung Cancer.
2005;
47
351-359
25
Groth S S, Whitson B A, Kuskowski M A. et al .
Impact of preoperative smoking status on postoperative complication rates and pulmonary function test results 1-year following pulmonary resection for non-small cell lung cancer.
Lung Cancer.
2009;
64
352-357
26
Mason D P, Subramanian S, Nowicki E R. et al .
Impact of smoking cessation before resection of lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database study.
Ann Thorac Surg.
2009;
88
362-370; discussion 370 – 371
28
Tonnesen H, Nielsen P R, Lauritzen J B. et al .
Smoking and alcohol intervention before surgery: evidence for best practice.
Br J Anaesth.
2009;
102
297-306
30
Konrad F X, Schreiber T, Brecht-Kraus D. et al .
Bronchial mucus transport in chronic smokers and nonsmokers during general anesthesia.
J Clin Anesth.
1993;
5
375-380
31
Verra F, Escudier E, Lebargy F. et al .
Ciliary abnormalities in bronchial epithelium of smokers, ex-smokers, and nonsmokers.
Am J Respir Crit Care Med.
1995;
151
630-634
32
Yamashita S, Yamaguchi H, Sakaguchi M. et al .
Effect of smoking on intraoperative sputum and postoperative pulmonary complication in minor surgical patients.
Respir Med.
2004;
98
760-766
33
Honda Y, Takahashi H, Kuroki Y. et al .
Decreased contents of surfactant proteins A and D in BAL fluids of healthy smokers.
Chest.
1996;
109
1006-1009
34
Mancini N M, Bene M C, Gerard H. et al .
Early effects of short-time cigarette smoking on the human lung: a study of bronchoalveolar lavage fluids.
Lung.
1993;
171
277-291
35
Bode F R, Dosman J, Martin R R. et al .
Reversibility of pulmonary function abnormalities in smokers. A prospective study of early diagnostic tests of small airways disease.
Am J Med.
1975;
59
43-52
36
Willemse B W, Postma D S, Timens W. et al .
The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation.
Eur Respir J.
2004;
23
464-476
38
Cryer P E, Haymond M W, Santiago J V. et al .
Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events.
N Engl J Med.
1976;
295
573-577
40
Turino G M.
Effect of carbon monoxide on the cardiorespiratory system. Carbon monoxide toxicity: physiology and biochemistry.
Circulation.
1981;
63
253A-259A
43
Morita H, Ikeda H, Haramaki N. et al .
Only two-week smoking cessation improves platelet aggregability and intraplatelet redox imbalance of long-term smokers.
J Am Coll Cardiol.
2005;
45
589-594
47
Ioka A, Nakamura M, Shirokawa N. et al .
Natural killer activity and its changes among participants in a smoking cessation intervention program – a prospective pilot study of 6 months’ duration.
J Epidemiol.
2001;
11
238-242
48
Hersey P, Prendergast D, Edwards A.
Effects of cigarette smoking on the immune system. Follow-up studies in normal subjects after cessation of smoking.
Med J Aust.
1983;
2
425-429
51
Sorensen L T, Toft B, Rygaard J. et al .
Smoking attenuates wound inflammation and proliferation while smoking cessation restores inflammation but not proliferation.
Wound Repair Regen.
2010;
18
186-192
52
Sorensen L T, Karlsmark T, Gottrup F.
Abstinence from smoking reduces incisional wound infection: a randomized controlled trial.
Ann Surg.
2003;
238
1-5
53
Sorensen L T, Zillmer R, Agren M. et al .
Effect of smoking, abstention, and nicotine patch on epidermal healing and collagenase in skin transudate.
Wound Repair Regen.
2009;
17
347-353
56
Garces Y I, Yang P, Parkinson J. et al .
The relationship between cigarette smoking and quality of life after lung cancer diagnosis.
Chest.
2004;
126
1733-1741
58
Baser S, Shannon V R, Eapen G A. et al .
Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status.
Chest.
2006;
130
1784-1790
59
Skold C M, Forslid J, Eklund A. et al .
Metabolic activity in human alveolar macrophages increases after cessation of smoking.
Inflammation.
1993;
17
345-352
60
Celermajer D S, Sorensen K E, Georgakopoulos D. et al .
Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults.
Circulation.
1993;
88
2149-2155
62
Kotani N, Kushikata T, Hashimoto H. et al .
Recovery of intraoperative microbicidal and inflammatory functions of alveolar immune cells after a tobacco smoke-free period.
Anesthesiology.
2001;
94
999-1006
1 Diese Übersichtsarbeit wurde in ihren Grundzügen auf dem 51. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V. im Rahmen eines Symposiums vorgestellt.
